(Q38901469)

7 September 2017

microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes (English)

1 reference

renal clear cell carcinoma

7 September 2017

1 reference

1 reference

1 reference

Nan Song

1

1 reference

7 September 2017

Xin Ma

2

1 reference

7 September 2017

Hongzhao Li

3

1 reference

7 September 2017

Yu Zhang

4

1 reference

7 September 2017

Xiaoxiong Wang

5

1 reference

7 September 2017

Pingkun Zhou

6

1 reference

7 September 2017

Xu Zhang

7

1 reference

7 September 2017

7 March 2015

1 reference

7 September 2017

1 reference

7 September 2017

33

1 reference

7 September 2017

5

1 reference

7 September 2017

205.e1-11

1 reference

7 September 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Expression of Von Hippel - Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Notch signaling in kidney development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Investigation of tumour supressor protein p53 in renal cell carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Circulating MicroRNA in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Transcription control of DAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Characterization of translation initiation factor 5 (eIF5) from Saccharomyces cerevisiae. Functional homology with mammalian eIF5 and the effect of depletion of eIF5 on protein synthesis in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Characterization of multiple mRNAs that encode mammalian translation initiation factor 5 (eIF-5)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

The microcosmos of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

MicroRNAs--targeting and target prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Expression and clinical significance of Notch receptors in human renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

The neurofibromatosis type 1 gene encodes a protein related to GAP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

The MDM2-p53 pathway: multiple roles in kidney development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.02.003

10.1016/J.UROLONC.2015.02.003

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference